1. Home
  2. NBH vs AXGN Comparison

NBH vs AXGN Comparison

Compare NBH & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBH
  • AXGN
  • Stock Information
  • Founded
  • NBH 2002
  • AXGN N/A
  • Country
  • NBH United States
  • AXGN United States
  • Employees
  • NBH N/A
  • AXGN N/A
  • Industry
  • NBH Finance/Investors Services
  • AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • NBH Finance
  • AXGN Health Care
  • Exchange
  • NBH Nasdaq
  • AXGN Nasdaq
  • Market Cap
  • NBH 308.6M
  • AXGN 290.2M
  • IPO Year
  • NBH N/A
  • AXGN N/A
  • Fundamental
  • Price
  • NBH $10.90
  • AXGN $9.24
  • Analyst Decision
  • NBH
  • AXGN Strong Buy
  • Analyst Count
  • NBH 0
  • AXGN 5
  • Target Price
  • NBH N/A
  • AXGN $13.00
  • AVG Volume (30 Days)
  • NBH 85.9K
  • AXGN 377.0K
  • Earning Date
  • NBH 01-01-0001
  • AXGN 08-05-2024
  • Dividend Yield
  • NBH 4.34%
  • AXGN N/A
  • EPS Growth
  • NBH N/A
  • AXGN N/A
  • EPS
  • NBH 0.12
  • AXGN N/A
  • Revenue
  • NBH N/A
  • AXGN $163,726,000.00
  • Revenue This Year
  • NBH N/A
  • AXGN $14.73
  • Revenue Next Year
  • NBH N/A
  • AXGN $12.98
  • P/E Ratio
  • NBH $87.04
  • AXGN N/A
  • Revenue Growth
  • NBH N/A
  • AXGN 13.51
  • 52 Week Low
  • NBH $8.75
  • AXGN $3.45
  • 52 Week High
  • NBH $11.01
  • AXGN $10.83
  • Technical
  • Relative Strength Index (RSI)
  • NBH 60.10
  • AXGN 69.49
  • Support Level
  • NBH $10.77
  • AXGN $8.17
  • Resistance Level
  • NBH $11.07
  • AXGN $9.54
  • Average True Range (ATR)
  • NBH 0.10
  • AXGN 0.47
  • MACD
  • NBH -0.01
  • AXGN 0.13
  • Stochastic Oscillator
  • NBH 60.23
  • AXGN 87.34

About NBH Neuberger Berman Municipal Fund Inc.

Neuberger Berman Intermediate Muni Fund is a closed-end management investment company that invests mainly in municipal securities. It aims to provide common stockholders a high level of current income exempt from Federal income tax.

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

Share on Social Networks: